Skip to main content
logo
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
5.73
-0.17 (-2.80%)
Jun 5, 2026, 11:34 AM EDT - Market open

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $7.47M in the twelve months ending March 31, 2026, up 3.42% year-over-year. In the year 2025, Taysha Gene Therapies had annual revenue of $9.77M with 17.28% growth.

Revenue (ttm)
$7.47M
Revenue Growth
+3.42%
P/S Ratio
220.20
Revenue / Employee
$75,465
Employees
99
Market Cap
1.65B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.77M1.44M17.28%
Dec 31, 20248.33M-7.12M-46.07%
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Innoviva420.69M
Syndax Pharmaceuticals217.17M
Nuvation Bio143.05M
Nurix Therapeutics71.78M
Agios Pharmaceuticals66.05M
uniQure18.09M
Capricor Therapeutics11.13M
Revenue Rankings

TSHA News

More News